February 7, 2025 06:27 AM EST
Financing
Startups

Sion­na inks $191M IPO for cys­tic fi­bro­sis pipeline as Aard­vark eyes $89M for its own list­ing

Kyle LaHucik

Senior Reporter

Cys­tic fi­bro­sis biotech Sion­na Ther­a­peu­tics will raise $191 mil­lion in its up­sized Nas­daq de­but on Fri­day, and meta­bol­ic dis­ease biotech Aard­vark …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Less than two years af­ter block­buster IPO, Ace­lyrin merges with Alu­mis to com­bine cash, as­sets

Long­time San­doz ex­ec an­nounces re­tire­ment; Lil­ly ap­points head of In­dia

Bris­tol My­ers prunes pipeline amid new round of cost cuts

No­vo Nordisk takes aim at Roche in he­mo­phil­ia A, but is way be­hind

Pfiz­er hires No­var­tis on­col­o­gy ex­ec to steer its can­cer am­bi­tions

As­traZeneca takes $753M charge on aban­doned com­ple­ment drug from Alex­ion deal

A service from the Financial Times